Efficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator Study

Aún no traducido Aún no traducido
Autores
Categoría Estudio primario
Registro de estudiosClinicalTrials.gov
Año 2013
This is a 12-month study investigating the effectiveness and safety of tofactinib in treating the signs and symptoms of active psoriatic arthritis and improving physical function and preserving bone structure in patients with an inadequate response to a traditional, nonbiologic disease-modifying antirheumatic drug. Adalimumab is used as a comparator.
Epistemonikos ID: 993ddc3bc006fb04b9d939180cd00b9995af09ff
First added on: Feb 15, 2022